Clough Capital Partners L P C4 Therapeutics, Inc. Transaction History

Clough Capital Partners L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$5.06 - $26.46 $1.8 Million - $9.42 Million	-356,181 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $2.01 Million - $3.34 Million	100,500 Added 39.31%	356,181 $8.64 Million
Q4 2021 Feb 14, 2022	SELL	$29.39 - $46.86 $2.7 Million - $4.3 Million	-91,819 Reduced 26.42%	255,681 $8.23 Million
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $7.97 Million - $11.2 Million	221,900 Added 176.67%	347,500 $15.5 Million
Q2 2021 Aug 16, 2021	BUY	$30.39 - $42.18 $3.82 Million - $5.3 Million	125,600 New	125,600 $4.75 Million

129

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $164M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.